Literature DB >> 11794701

CD3+CD4-CD8-TCR-alphabeta+ T-cell lymphoma with clinical features of primary effusion lymphoma: an autopsy case.

Y Yamamoto1, H Kitajima, H Sakihana, T Shigeki, S Fukuhara.   

Abstract

We report an unusual case of T-cell lymphoma presenting as ascites. A 72-year-old HIV-negative woman was admitted to our hospital for abdominal discomfort associated with increasing abdominal girth over the course of 1 month. Physical examination showed a tense and distended abdomen and edema of the lower extremities. There was no hepatosplenomegaly or lymphadenopathy. A computed tomographic scan of the abdomen and chest showed massive ascites and pleural effusions, but there was no evidence of tumor masses or lymph node enlargement. The cytospin prepared from the peritoneal fluid was hypercellular and composed of a population of monotonous, large cells containing fine chromatin. No herpesvirus-8 (HHV-8) DNA was detected by polymerase chain reaction in the cells. Immunohistochemistry showed the neoplastic cells to be CD3+, CD4, CD7+. CD8-, CD34-, CD56, and TCR-alphabeta+. Repeated cytogenetic studies showed common abnormalities of del(1) (p11p22), +i(7)(ql0), and t(11:14)(q23;q11). The morphologic and immunologic findings were suggestive of peripheral T-cell lymphoma (PTCL), unspecified. This case suggests that some PTCLs with clonal chromosomal aberrations can exhibit peculiar serosal spreading in the absence of HHV-8 infection.

Entities:  

Mesh:

Year:  2001        PMID: 11794701     DOI: 10.1007/bf02982089

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

Review 1.  Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm.

Authors:  D S Karcher; S Alkan
Journal:  Hum Pathol       Date:  1997-07       Impact factor: 3.466

2.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

3.  Chromosome abnormalities in peripheral T-cell lymphoma.

Authors:  S Lepretre; G Buchonnet; A Stamatoullas; P Lenain; C Duval; J d'Anjou; M P Callat; H Tilly; C Bastard
Journal:  Cancer Genet Cytogenet       Date:  2000-02

Review 4.  Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations.

Authors:  O A Bernard; R Berger
Journal:  Genes Chromosomes Cancer       Date:  1995-06       Impact factor: 5.006

5.  Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.

Authors:  A Melnyk; A Rodriguez; W C Pugh; F Cabannillas
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

6.  Incidence of cytomegalic inclusion disease.

Authors:  S Takayama
Journal:  Bull Tokyo Med Dent Univ       Date:  1969-03

7.  The phenotypic diversity of peripheral T-cell lymphomas: the Southeastern Cancer Study Group experience.

Authors:  M J Borowitz; T A Reichert; R K Brynes; J B Cousar; C C Whitcomb; R D Collins; J D Crissman; G E Byrne
Journal:  Hum Pathol       Date:  1986-06       Impact factor: 3.466

8.  Molecular analysis of a t(11;14)(q23;q11) from a patient with null-cell acute lymphoblastic leukemia.

Authors:  R C Burnett; R Espinosa; T B Shows; R L Eddy; M M LeBeau; J D Rowley; M O Diaz
Journal:  Genes Chromosomes Cancer       Date:  1993-05       Impact factor: 5.006

9.  Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.

Authors:  J F Moley; M B Brother; C T Fong; P S White; S B Baylin; B Nelkin; S A Wells; G M Brodeur
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  6 in total

Review 1.  KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states.

Authors:  Serge Alexanian; Jonathan Said; Mark Lones; Sheeja T Pullarkat
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

Review 2.  Durable remission by sobuzoxane in an HIV-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma.

Authors:  Yoriko Inoue; Kunihiro Tsukasaki; Kazuhiro Nagai; Hisashi Soda; Masao Tomonaga
Journal:  Int J Hematol       Date:  2004-04       Impact factor: 2.490

Review 3.  Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Authors:  C Agostinelli; P P Piccaluga; P Went; M Rossi; A Gazzola; S Righi; T Sista; C Campidelli; P L Zinzani; B Falini; S A Pileri
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

4.  Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report.

Authors:  Miao-Miao Wu; Wen-Jun Fu; Jia Wu; Lin-Lin Zhu; Ting Niu; Rong Yang; Jin Yao; Qiang Lu; Xiao-Yang Liao
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

5.  HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature.

Authors:  Neeraj Saini; Ephraim P Hochberg; Erica A Linden; Smita Jha; Heinz K Grohs; Aliyah R Sohani
Journal:  Case Rep Oncol Med       Date:  2013-01-16

Review 6.  Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV.

Authors:  Chih-Yi Liu; Bo-Jung Chen; Shih-Sung Chuang
Journal:  Diagnostics (Basel)       Date:  2022-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.